Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU6-798P** refers to a **pseudogene** copy of the U6 small nuclear RNA (snRNA) gene. The canonical U6 snRNA is an essential non-coding RNA that plays a critical role in the spliceosome, the machinery responsible for excising introns from pre-mRNA during RNA splicing in eukaryotic cells[3][1]. However, **RNU6-798P** is specifically annotated as a pseudogene[2], meaning it is a non-functional, non-protein-coding sequence that resembles the functional U6 snRNA gene but does not produce an active RNA product. Pseudogenes like RNU6-798P generally do not encode functional molecules and are not considered therapeutic targets, receptors, enzymes, or other classical drug targets. They may have regulatory or evolutionary significance, but there is no evidence that RNU6-798P has a direct biological function or involvement in human disease based on current knowledge.\n\n**Clarification:**\n- The entry is likely **not a therapeutic target** because pseudogenes, by definition, are generally non-functional and are not directly implicated as molecular targets for drugs, biomarkers, or therapeutic development[2][4].\n- There is **no evidence of RNU6-798P being involved in biological processes** such as signal transduction, cell cycle regulation, or disease.\n- **No known drugs, disease associations, or safety concerns** are documented for this pseudogene.\n\n**Note:** \nThis target may be flagged as \"incorrect\" or \"not a target\" for most drug discovery or therapeutic contexts, as it is not a functional molecule or receptor, and its inclusion in target lists is likely an error or a misunderstanding of pseudogene biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 798, pseudogene (RNU6-798P).